Skip to content

BioInvent International AB Sustainability Reports

BioInvent International AB is a Swedish biotech company focused on the research and development of novel immunotherapies for cancer treatment.

Sector: Health Care

Country: Sweden

Exchange: Nasdaq Stockholm

ISIN: SE0000789711

20 reports from 2007 to 2025